PITTSBURGH, Jan. 6, 2015 /PRNewswire/ -- Cohera Medical, Inc. ®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received a letter from the U.S. Food and Drug Administration (FDA) that the pending Premarket Approval Application (PMA) for its TissuGlu® Surgical Adhesi..."> PITTSBURGH, Jan. 6, 2015 /PRNewswire/ -- Cohera Medical, Inc. ®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received a letter from the U.S. Food and Drug Administration (FDA) that the pending Premarket Approval Application (PMA) for its TissuGlu® Surgical Adhesi..." /> PITTSBURGH, Jan. 6, 2015 /PRNewswire/ -- Cohera Medical, Inc. ®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received a letter from the U.S. Food and Drug Administration (FDA) that the pending Premarket Approval Application (PMA) for its TissuGlu® Surgical Adhesi..." />